CMAJ/JAMC Special supplement
Supplément spécial

Table 2: Recommended opioid agonist drugs
 
Drug Route Equivalent
dose; mg
Duration; h Comments

MorphineSubcutaneous
Oral
10
30
3-4
3-4
Standard for comparison

CodeineOral2002-4Usually combined with a nonopioid

OxycodoneOral202-4Used for step 2* with a nonopioid. Used for step 3 as a single agent

HydromorphoneSubcutaneous
Oral
2
6
2-4
2-4

DiamorphineSubcutaneous53-4Reserved for patients with local reaction to other opioids

Fentanyl transdermalApproximately 100 to 200 times the potency of morphine in an acute pain context. Equivalence in chronic pain is not well established. Patches deliver 25, 50, 75 and 100 µg/h. Morphine subcutaneously every 4 h is approximately equivalent to a 25 to 50 µg/h patch.

Slow-release preparations of morphine, codeine, oxycodone and hydromorphine with a duration of action of approximately 12 h are available in Canada.
*World Health Organization 3-step approach to the use of analgesics


Return to Guideline 10